Medical degree from Federal University of Rio de Janeiro (1977), Master (1980) and PhD (1985) in Biological Sciences from Federal University of Rio de Janeiro. Postdoctoral fellow at Yale University (1985-1987). Faculty member at Federal University of Rio de Janeiro since 1980. Vice-Director of the Carlos Chagas Filho Institute of Biophysics / UFRJ. Founding member and President of the Brazilian Association of Cellular and Gene Therapy (ABTCel). Titular member of the Brazilian Academy of Sciences (ABC) since 2006. National Order of Scientific Merit (2006). Currently Full professor at Federal University of Rio de Janeiro and Head of the Laboratory of Cellular and Molecular Neurobiology. Experience in the area of Neuroscience and Neurology working in basic, pre-clinical and clinical research in cell and gene therapies in diseases and injuries of the Nervous System. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
One of the major challenges encountered in translational research applied to rare neurodegenerative diseases (NDs), such as Amyotrophic Lateral Sclerosis (ALS), is the functional evaluation of new variants potentially associated with these diseases. Novel gene variants of uncertain significance (VUS) are often identified in patients with NDs, highlighting the need for functional validatio…
Stroke is the second leading cause of death and the third leading cause of death and disability combined globally, and can be divided into ischemic or hemorrhagic. In Brazil, since 2019, stroke has surpassed heart attack as the leading cause of death in the country, and its incidence ranges from 54.3 to 77 per 100,000 inhabitants, with 50,133 deaths recorded until August 2024. The accumul…
The Endocannabinoid System constitutes a complex set of pathways signaling whose functions range from presynaptic neuronal inhibition to immunomodulation. The endogenous messengers of the system are lipids synthesized on demand (anandamide and 2-arachidonoyl glycerol) that interact with G protein-coupled receptors (CB1 and CB2). CB1 receptors arefound primarily in the central nervous syst…
| 3 / 3 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID